Data Simulation Enhances Ethical Research Standards
genESOM AI Cuts Animal Drug Testing by 50 Percent
Researchers at Goethe and Marburg universities develop generative AI to simulate pharmacological data points.
A laboratory screen displaying 3D molecular models and scientific data graphs in a high-tech medical research setting.
Photo: Avantgarde News
Researchers at Goethe University Frankfurt and Marburg University have developed a generative artificial intelligence system called genESOM [1][2]. The technology simulates experimental data points to assist in pharmacological drug discovery [1][3]. By using these simulations, scientists can maintain high statistical significance while conducting fewer physical trials [2].
This new system has successfully reduced the number of mice used in laboratory experiments by 30 to 50 percent [1][2]. genESOM works by augmenting existing datasets, which allows researchers to achieve reliable results with fewer live subjects [3]. The breakthrough provides a more ethical path for future medical research and drug development [1].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
- 1.↗
drugtargetreview.com
https://www.drugtargetreview.com/ai-system-reduces-animal-testing-in-drug-discovery-by-50-percent/2135437.article
- 2.↗
uni-frankfurt.de
https://www.uni-frankfurt.de/en/newsroom/meldungen/pressemitteilungen/2026/generative-kuenstliche-intelligenz-kann-tierversuchszahl-deutlich-verringern
- 3.↗
uni-marburg.de
https://www.uni-marburg.de/en/prfolder-en/news/generative-artificial-intelligence-can-significantly-reduce-the-number-of-animal-experiments
Related stories
View allTopics
About the author
Avantgarde News Desk covers data simulation enhances ethical research standards and editorial analysis for Avantgarde News.